FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Krigsvold Terah Renee 2. Date of Event Requiring Statement (Month/Day/Year) 12/30/2025 3. Issuer Name and Ticker or Trading Symbol INVO Fertility, Inc. [IVF] (Last) (First) (Middle) C/O INVO FERTILITY, INC., 5582 BROADCAST COURT 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Financial Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) SARASOTA, FL 34240 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 1 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	01/03/2031	Common Stock	3	$17,683.2	D
Stock Option (right to buy)	(2)	02/10/2032	Common Stock	3	$17,280	D
Stock Option (right to buy)	12/29/2022	12/28/2032	Common Stock	2	$2,304	D
Stock Option (right to buy)	01/13/2023	01/12/2033	Common Stock	2	$2,983.68	D
Stock Option (right to buy)	01/31/2023	01/30/2033	Common Stock	2	$3,882.24	D
Stock Option (right to buy)	(3)	05/17/2033	Common Stock	11	$2,119.68	D
Stock Option (right to buy)	(4)	08/25/2035	Common Stock	4,375	$8.96	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Krigsvold Terah Renee C/O INVO FERTILITY, INC. 5582 BROADCAST COURT SARASOTA, FL 34240			Chief Financial Officer

Signatures

/s/ Terah Krigsvold		01/13/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The option vested in monthly increments over a period of 36 months from January 1, 2021.
(2)	The option vested in monthly increments over a period of 36 months from February 11, 2022.
(3)	The option vests in 12 equal installments beginning on May 18, 2023 and on the last day of each calendar quarter thereafter until fully vested.
(4)	The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.